In a rabbit model of Myh7-Q403-driven cardiac hypertrophy, treatment with simvastatin reduced ERK phosphorylation and did not affect Rac1 GTP-loading, however it did appear to mildly reduce Rac1 membrane localization [63]. Here, MAPK1 is linked to cardiac hypertrophy.